Results 1 to 2 of 2

Thread: InVivo Therapeutics Announces Data on Novel Hydrogel Technology in Spinal Cord Injury

Hybrid View

Previous Post Previous Post   Next Post Next Post
  1. #1

    InVivo Therapeutics Announces Data on Novel Hydrogel Technology in Spinal Cord Injury

    InVivo Therapeutics Announces Data on Novel Hydrogel Technology in Spinal Cord Injury and Neurosurgical Applications Presented at 2011 Annual Meeting of the AANS/CNS Section on Disorders of the Spine and Peripheral Nerves
    Novel Hydrogel Technology May Enable Local, Controlled Drug Delivery in Treatment of Spinal Cord Injury


    CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that a poster highlighting data from a laboratory investigation of the company’s injectable hydrogel technology for local, controlled-release drug delivery, is being presented at the 2011 Annual Meeting of the American Association of Neurological Surgeons (AANS)/Central Nervous System (CNS) Section on Disorders of the Spine and Peripheral Nerves, which is being held March 9-12 in Phoenix, Arizona.

    read...

    http://www.businesswire.com/news/hom...hnology-Spinal
    Last edited by manouli; 03-11-2011 at 11:37 PM.

  2. #2
    Along with its biocompatible polymer scaffold device, which the company plans to move into a clinical study in the second half of this year, InVivo is developing its novel hydrogel technology as a treatment for SCI. Both technologies focus on protection of the spinal cord and prevention of secondary injury, an approach which, unlike any currently available treatment, is designed to address the underlying pathology of a SCI.
    It's slightly ambiguous whether this is intended for acute or chronic injuries - or are they suggesting both?

    Dr. Young, you've stated elsewhere that there are no studies confirming any negative side effects for the current delivery of methylprednisolone - do you see this as potentially more beneficial?

Similar Threads

  1. Replies: 1
    Last Post: 10-15-2010, 08:53 PM
  2. Replies: 0
    Last Post: 07-10-2008, 04:02 PM
  3. Acorda Therapeutics CEO Inducted into Spinal Cord Injury Hall of Fame
    By Max in forum Funding, Legislation, & Advocacy
    Replies: 3
    Last Post: 11-13-2007, 01:55 PM
  4. Replies: 0
    Last Post: 11-12-2007, 10:08 AM
  5. Replies: 0
    Last Post: 09-10-2003, 07:52 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •